These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23023214)

  • 41. The intranasal vaccination of pregnant dams with Intimin and EspB confers protection in neonatal mice from Escherichia coli (EHEC) O157:H7 infection.
    Rabinovitz BC; Larzábal M; Vilte DA; Cataldi A; Mercado EC
    Vaccine; 2016 May; 34(25):2793-7. PubMed ID: 27129423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection.
    Dean-Nystrom EA; Gansheroff LJ; Mills M; Moon HW; O'Brien AD
    Infect Immun; 2002 May; 70(5):2414-8. PubMed ID: 11953378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterologous expression of Intimin and IpaB fusion protein in Lactococcus lactis and its mucosal delivery elicit protection against pathogenicity of Escherichia coli O157 and Shigella flexneri in a murine model.
    Sagi S; Konduru B; Parida M
    Int Immunopharmacol; 2020 Aug; 85():106617. PubMed ID: 32464569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chitosan nano-structure loaded with recombinant
    Khanifar J; Salmanian AH; Haji Hosseini R; Amani J; Kazemi R
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2593-2604. PubMed ID: 31240960
    [No Abstract]   [Full Text] [Related]  

  • 45. Isolation and characterization of mini-Tn5Km2 insertion mutants of enterohemorrhagic Escherichia coli O157:H7 deficient in adherence to Caco-2 cells.
    Tatsuno I; Kimura H; Okutani A; Kanamaru K; Abe H; Nagai S; Makino K; Shinagawa H; Yoshida M; Sato K; Nakamoto J; Tobe T; Sasakawa C
    Infect Immun; 2000 Oct; 68(10):5943-52. PubMed ID: 10992506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Designing of a chimeric protein contains StxB, intimin and EscC against toxicity and adherence of enterohemorrhagic Escherichia coli O157:H7 and evaluation of serum antibody titers against it.
    Sadri Najafabadi Z; Nazarian S; Kargar M; Kafilzadeh F
    Mol Immunol; 2021 Jun; 134():218-227. PubMed ID: 33823320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Translocated intimin receptors (Tir) of Shiga-toxigenic Escherichia coli isolates belonging to serogroups O26, O111, and O157 react with sera from patients with hemolytic-uremic syndrome and exhibit marked sequence heterogeneity.
    Paton AW; Manning PA; Woodrow MC; Paton JC
    Infect Immun; 1998 Nov; 66(11):5580-6. PubMed ID: 9784578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral immunization with a plant-derived chimeric protein in mice: Toward the development of a multipotent edible vaccine against E. coli O157: H7 and ETEC.
    Shojaei Jeshvaghani F; Amani J; Kazemi R; Karimi Rahjerdi A; Jafari M; Abbasi S; Salmanian AH
    Immunobiology; 2019 Mar; 224(2):262-269. PubMed ID: 30579628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody response of patients infected with verocytotoxin-producing Escherichia coli to protein antigens encoded on the LEE locus.
    Jenkins C; Chart H; Smith HR; Hartland EL; Batchelor M; Delahay RM; Dougan G; Frankel G
    J Med Microbiol; 2000 Jan; 49(1):97-101. PubMed ID: 10628831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Preparation and characterization of monoclonal antibody against Enterohemorrhagic Escherichia coli O157:H7 EspA].
    Yu S; Luo P; Chen HZ; Li HX; Mao XH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):657-9. PubMed ID: 17618593
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a dual vaccine for prevention of Brucella abortus infection and Escherichia coli O157:H7 intestinal colonization.
    Iannino F; Herrmann CK; Roset MS; Briones G
    Vaccine; 2015 May; 33(19):2248-2253. PubMed ID: 25820069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Avian- and mammalian-derived antibodies against adherence-associated proteins inhibit host cell colonization by Escherichia coli O157:H7.
    Cook SR; Maiti PK; DeVinney R; Allen-Vercoe E; Bach SJ; McAllister TA
    J Appl Microbiol; 2007 Oct; 103(4):1206-19. PubMed ID: 17897225
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant anti-EspA antibodies block Escherichia coli O157:H7-induced attaching and effacing lesions in vitro.
    La Ragione RM; Patel S; Maddison B; Woodward MJ; Best A; Whitelam GC; Gough KC
    Microbes Infect; 2006 Feb; 8(2):426-33. PubMed ID: 16298154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In silico design, production and immunization evaluation of a recombinant bivalent fusion protein candidate vaccine against E. coli O157:H7.
    Samiei H; Nazarian S; Hajizade A; Kordbacheh E
    Int Immunopharmacol; 2023 Jan; 114():109464. PubMed ID: 36450206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intimin type influences the site of human intestinal mucosal colonisation by enterohaemorrhagic Escherichia coli O157:H7.
    Fitzhenry RJ; Pickard DJ; Hartland EL; Reece S; Dougan G; Phillips AD; Frankel G
    Gut; 2002 Feb; 50(2):180-5. PubMed ID: 11788556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adhesion of enterohemorrhagic Escherichia coli O157:H7 to the intestinal epithelia is essential for inducing secretory IgA antibody production in the intestine of mice.
    Nagano K; Taguchi K; Tokoro S; Tatsuno I; Mori H
    Biol Pharm Bull; 2014; 37(3):409-16. PubMed ID: 24583860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
    Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A review on strategies for decreasing E. coli O157:H7 risk in animals.
    Saeedi P; Yazdanparast M; Behzadi E; Salmanian AH; Mousavi SL; Nazarian S; Amani J
    Microb Pathog; 2017 Feb; 103():186-195. PubMed ID: 28062285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization.
    Ahmed B; Loos M; Vanrompay D; Cox E
    Vaccine; 2014 Jun; 32(31):3909-16. PubMed ID: 24877767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Studies of Escherichia coli O157:H7 Conjugate Vaccines in Adults and Young Children.
    Szu SC; Ahmed A
    Microbiol Spectr; 2014 Dec; 2(6):. PubMed ID: 26104443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.